Potassium binders for chronic hyperkalaemia in people with chronic kidney disease-Reference-Cited by-同舟云学术

Potassium binders for chronic hyperkalaemia in people with chronic kidney disease

Published:2020-06-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Natale Patrizia¹²,Palmer Suetonia C³,Ruospo Marinella¹²,Saglimbene Valeria M¹²,Strippoli Giovanni FM¹²⁴

Affiliation:

1. Department of Emergency and Organ Transplantation; University of Bari; Bari Italy

2. Sydney School of Public Health; The University of Sydney; Sydney Australia

3. Department of Medicine; University of Otago Christchurch; Christchurch New Zealand

4. Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference147 articles.

1. Patiromer to enable spironolactone use in the treatment of patients with resistant hypertension and chronic kidney disease: rationale and design of the AMBER study;Agarwal;American Journal of Nephrology,2018

2. Patiromer to enable spironolactone in patients with resistant hypertension and CKD: primary results of amber [abstract];Agarwal;American Journal of Kidney Diseases,2019

3. Patiromer vs. placebo to enable spironolactone in patients with resistant hypertension and CKD according to baseline kidney function (AMBER trial) [abstract no: TH-OR052];Agarwal;Journal of the American Society of Nephrology,2019

4. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial;Agarwal;Lancet,2019

5. Patiromer vs. placebo to enable spironolactone in patients with resistant hypertension and chronic kidney disease (AMBER): results in prespecified subgroups [abstract];Williams;Journal of Cardiac Failure,2019

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semaglutide and Patients Receiving Hemodialysis: Case Reports of Unexpected Benefits for Hyperphosphatemia and Hyperkalemia;Canadian Journal of Hospital Pharmacy;2024-05-08

2. Role of Nutrients in Pediatric Non-Dialysis Chronic Kidney Disease: From Pathogenesis to Correct Supplementation;Biomedicines;2024-04-19

3. Protocol for systematic review and meta-analysis for randomized clinical trials on patiromer efficacy and safety in subjects with heart failure;PHARM PRACT-GRANADA;2024

4. Acute Hyperkalemia Management in the Emergency Department;Advanced Emergency Nursing Journal;2024-01

5. Overview of the safety, efficiency, and potential mechanisms of finerenone for diabetic kidney diseases;Frontiers in Endocrinology;2023-12-20